NTAGI chief says Corbevax Covid vaccine is safe, provides high antibody levels - The country’s central drug authority is soon expected to give final approval to Corbevax, which is a two-dose vaccine.
Dr NK Arora, the chairman of the Covid-19 working group of the NTAGI said, "The galloping increase in the number of Covid cases over the last one week is indicative of the third wave, as is being seen in several other countries across the globe."